Skip to content

Neural Circuit Based Taichi Yunshou Action Observation Training Combined With Motor Imagery for Stroke Rehabilitation

A Randomized Controlled Trial for Neural Circuit Based Taichi Yunshou Action Observation Training Combined With Motor Imagery for Stroke Rehabilitation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002625
Enrollment
Unknown
Registered
2019-09-27
Start date
2019-09-23
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Sponsors

National Natural Science Foundation of China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The first cerebral infarction which accords with the diagnosis standard of Chinese and Western medicine and belongs to unilateral brain; 2. Aged 20-75 years, regardless of gender; 3. Right-handed; 4. The onset was more than 1 month and less than 2 years. 5. Primary school and above education level; 6. No severe aphasia (Aphasia Screening Scale); 7. Simple Mental State Scale screening results showed that there was no cognitive impairment. 8. The degree of motor dysfunction of affected limbs was Brunnstrom grade II-VI. 9. It has certain motor imagery function. The motor imagery questionnaire has 25 points or more. 10. Can tolerate half an hour to one hour of training or testing; 11. Volunteer to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Neurological diseases, including epilepsy, which seriously affect the completion of the trial program. 2. there are contraindications of MRI, such as pacemaker, metal implant, etc. 3. Excessive pain exists in limb joints. 4. Cranial fractures and/or severe head injuries; 5. History of head and/or brain surgery; 6. Severe visual or auditory impairment, unable to cooperate with training; 7. Three cycles of antidepressants and psychotropic tranquilizers were taken 30 days before the trial. 8. Other drugs to reduce seizure threshold were taken 30 days before the trial. 9. Severe diseases of liver, kidney, heart, lung and blood system were found. 10. Excessive sensitivity or mental illness; 11. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer motor assessment upper extremity scale;

Secondary

MeasureTime frame
Berg balance scale, BBS;Beck depression inventory, BDI;modified Barthel index, MBI;World Health Organization Quality of Life Assessment Instrument Brief Version, WHOQOL-BREF;Functional magnetic resonance imaging;Fugl-Meyer motor assessment Lower extremities scale;Structural Brain Imaging;

Countries

China

Contacts

Public ContactChunlei Shan

Shanghai University of Traditional Chinese Medicine

shanclhappy@163.com+86 18616974986

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026